Impact of the implantable cardioverter defibrillator on confidence to undertake physical activity in inherited heart disease: A cross-sectional study

Background: Physical activity is associated with improved quality of life. Patients with an implantable cardioverter defibrillator (ICD) face unique clinical and psychological challenges. Factors such as fear of ICD shock may negatively impact on physical activity, while a sense of protection gained from the ICD may instil confidence to be active. Aim: We aimed to examine the impact of an ICD on physical activity levels and factors associated with amount of activity. Methods: Two cross-sectional studies were conducted. Accelerometer data (seven-day) was collected in March–November 2015 for 63 consecutively recruited hypertrophic cardiomyopathy patients, with or without an ICD, aged ⩾18 years. A survey study was conducted in July–August 2016 of 155 individuals aged ⩾18 years with an inherited heart disease and an ICD in situ. Results: Based on the International Physical Activity Questionnaire, mean leisure time physical activity was 239 ± 300 min/week with 51% meeting physical activity guidelines. Accelerometry showed that mean moderate–vigorous physical activity was the same for patients with and without an ICD (254 ± 139 min/week versus 300 ± 150 min/week, p=0.23). Nearly half of survey participants (n=73) said their device made them more confident to exercise. Being anxious about ICD shocks was the only factor associated with not meeting physical activity guidelines. Conclusions: Patients with inherited heart disease adjust differently to their ICD device, and for many it has no impact on physical activity. Discussion regarding the appropriate level of physical activity and potential barriers will ensure best possible outcomes in this unique patient group.

[1]  A. Timperio,et al.  Physical activity in hypertrophic cardiomyopathy: prevalence of inactivity and perceived barriers , 2016, Open Heart.

[2]  W. Haskell,et al.  Adherence to an Aerobic Exercise Intervention after an Implantable Cardioverter Defibrillator (ICD) , 2016, Pacing and clinical electrophysiology : PACE.

[3]  S. Normand,et al.  Patient Activity and Survival Following Implantable Cardioverter-Defibrillator Implantation: The ALTITUDE Activity Study , 2015, Journal of the American Heart Association.

[4]  K. Ball,et al.  Social determinants of health in the setting of hypertrophic cardiomyopathy. , 2015, International journal of cardiology.

[5]  S. Sears,et al.  Examination of the differential impacts of antitachycardia pacing vs. shock on patient activity in the EMPIRIC study. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[6]  J. Svendsen,et al.  Physical activity in primary versus secondary prevention indication implantable cardioverter defibrillator recipients 6-12 months after implantation - a cross-sectional study with register follow up. , 2015, Archives of physical medicine and rehabilitation.

[7]  J. Svendsen,et al.  Comprehensive cardiac rehabilitation improves outcome for patients with implantable cardioverter defibrillator. Findings from the COPE-ICD randomised clinical trial , 2015, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[8]  K. Ball,et al.  Challenges of Exercise Recommendations and Sports Participation in Genetic Heart Disease Patients , 2015, Circulation. Cardiovascular genetics.

[9]  H. Heidbuchel,et al.  Exercise and competitive sports in patients with an implantable cardioverter-defibrillator. , 2014, European Heart Journal.

[10]  S. Sears,et al.  Shocktivity: ABILITY AND AVOIDANCE OF DAILY ACTIVITY BEHAVIORS IN ICD PATIENTS , 2014, Journal of cardiopulmonary rehabilitation and prevention.

[11]  C. Semsarian,et al.  The Australian Genetic Heart Disease Registry. , 2013, International journal of cardiology.

[12]  T. Lüscher,et al.  Exercise: friend or foe? , 2013, Nature Reviews Cardiology.

[13]  Carolyn Y. Ho,et al.  Genetic testing for inherited heart disease. , 2013, Circulation.

[14]  M. Link,et al.  Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Long-Term Results of a Prospective Multinational Registry. , 2013, Circulation.

[15]  M. Link,et al.  Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Results of a Prospective, Multinational Registry , 2013, Circulation.

[16]  S. Sears,et al.  Disease-Specific Quality of Life—Patient Acceptance: Racial and Gender Differences in Patients With Implantable Cardioverter Defibrillators , 2013, The Journal of cardiovascular nursing.

[17]  M. Ackerman,et al.  Return to play? Athletes with congenital long QT syndrome , 2012, British Journal of Sports Medicine.

[18]  J. Denollet,et al.  Monitoring Device Acceptance in Implantable Cardioverter Defibrillator Patients Using the Florida Patient Acceptance Survey , 2012, Pacing and clinical electrophysiology : PACE.

[19]  Peter F. Lovibond,et al.  Depression Anxiety Stress Scales , 2011 .

[20]  Carolyn M. Reilly,et al.  Effect of a Psychoeducational Intervention on Depression, Anxiety, and Health Resource Use in Implantable Cardioverter Defibrillator Patients , 2009, Pacing and clinical electrophysiology : PACE.

[21]  R. Kobza,et al.  Leisure‐Time Activities of Patients with ICDs: Findings of a Survey with Respect to Sports Activity, High Altitude Stays, and Driving Patterns , 2008, Pacing and clinical electrophysiology : PACE.

[22]  Eloisa Arbustini,et al.  Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[23]  Pietro Delise,et al.  Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions Part II: Ventricular arrhythmias, channelopathies and implantable defibrillators , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[24]  D. Corrado,et al.  Exercise and the Risk of Sudden Cardiac Death , 2006, Herz Kardiovaskuläre Erkrankungen.

[25]  Emily A. Kuhl,et al.  Measurement of Patient Fears About Implantable Cardioverter Defibrillator Shock: An Initial Evaluation of the Florida Shock Anxiety Scale , 2006, Pacing and clinical electrophysiology : PACE.

[26]  Stewart G Trost,et al.  Conducting accelerometer-based activity assessments in field-based research. , 2005, Medicine and science in sports and exercise.

[27]  S. Sears,et al.  Measuring Patient Acceptance of Implantable Cardiac Device Therapy: , 2005, Journal of cardiovascular electrophysiology.

[28]  Michael J Ackerman,et al.  Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. , 2004, Circulation.

[29]  J. Dimarco,et al.  Implantable cardioverter-defibrillators. , 2003, The New England journal of medicine.

[30]  B. Ainsworth,et al.  International physical activity questionnaire: 12-country reliability and validity. , 2003, Medicine and science in sports and exercise.

[31]  Ilse De Bourdeaudhuij,et al.  Addressing overreporting on the International Physical Activity Questionnaire (IPAQ) telephone survey with a population sample , 2003, Public Health Nutrition.

[32]  I. Gelder,et al.  Fear of exercise and health-related quality of life in patients with an implantable cardioverter defibrillator , 2003, International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation.

[33]  J. Sallis Age-related decline in physical activity: a synthesis of human and animal studies. , 2000, Medicine and science in sports and exercise.

[34]  A. Dubin,et al.  Quality‐of‐Life in Patients Receiving Implantable Cardioverter Defibrillators At or Before Age 40 , 1996, Pacing and clinical electrophysiology : PACE.

[35]  P. Lovibond,et al.  The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. , 1995, Behaviour research and therapy.

[36]  R. Niaura,et al.  Self-efficacy and the stages of exercise behavior change. , 1992, Research quarterly for exercise and sport.

[37]  P. Bennett,et al.  Living with an implantable cardioverter defibrillator: The patients' experience. , 2016, Heart & lung : the journal of critical care.

[38]  J. Salmon,et al.  Predicting healthy lifestyle patterns among retirement age older adults in the WELL study: a latent class analysis of sex differences. , 2014, Maturitas.